Status:
COMPLETED
Protein Supplementation and Endurance Exercise Adaptations
Lead Sponsor:
Wageningen University
Conditions:
Exercise
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
Participants will perform three endurance training sessions weekly for 12 weeks. All participants will be randomly assigned to the protein supplementation group or the placebo (iso-caloric carbohydrat...
Detailed Description
In the proposed study, the effects of protein supplementation after training and before sleep on VO2max and performance will be assessed during 12 weeks endurance exercise training in untrained health...
Eligibility Criteria
Inclusion
- Male
- Age between 18 and 30 years of age
- BMI between 18.5 - 25 kg/m2
- Recreationally active, performing sports on a non-competitive basis
- Maximal wattage of \> 5 watt per kg bodyweight (screening measurement)
- Willing to give muscle biopsies
- Willing to give blood samples
- Having a general-practitioner
- Consumption of alcohol beverages is less than 21 per week
- Able to perform three exercise sessions weekly for 10 weeks
Exclusion
- Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, liver or renal disease, diabetes mellitus type 1 or 2)
- Having a lactose and/or gluten intolerance
- Use of systemic medication (with the exception of antihistaminic medication and the use of occasional painkillers)
- (Chronic) injuries of the locomotor system (e.g. musculoskeletal/orthopedic disorders) that can interfere with the intervention
- Participants who are enrolled in an interventional biomedical research project or have received an investigational new drug or product with the last 30 days prior to screening.
- Smokers and use of illicit drugs
- Blood donor during the study and in the three months before start of the study
- Employed, or intern, or working on a thesis at the department of Human Nutrition at Wageningen University \& Research
- Participating in another scientific study (except EetMeetWeet)
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03462381
Start Date
August 1 2017
End Date
June 1 2018
Last Update
March 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wageningen University & Research
Wageningen, Gelderland, Netherlands, 6708 WE